Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Second Harmonic Generation Spectroscopy of Membrane Probe Dynamics in Gram-Positive Bacteria.

Miller LN, Brewer WT, Williams JD, Fozo EM, Calhoun TR.

Biophys J. 2019 Oct 15;117(8):1419-1428. doi: 10.1016/j.bpj.2019.09.014. Epub 2019 Sep 18.

PMID:
31586521
2.

Genetic Ablation of Neural Progenitor Cells Impairs Acquisition of Trace Eyeblink Conditioning.

Miller LN, Weiss C, Disterhoft JF.

eNeuro. 2019 Oct 4;6(5). pii: ENEURO.0251-19.2019. doi: 10.1523/ENEURO.0251-19.2019. Print 2019 Sep/Oct.

3.

Mg2+ restriction downregulates NCC through NEDD4-2 and prevents its activation by hypokalemia.

Ferdaus MZ, Mukherjee A, Nelson JW, Blatt PJ, Miller LN, Terker AS, Staub O, Lin DH, McCormick JA.

Am J Physiol Renal Physiol. 2019 Oct 1;317(4):F825-F838. doi: 10.1152/ajprenal.00216.2019. Epub 2019 Jul 31.

PMID:
31364380
4.

Retrospective Analysis of Oxcarbazepine in Pregnant Women With Substance Use Disorders: Focus on Safety.

Johnson KD, Miller LN, Pouliot JD, Martin PR.

J Pharm Pract. 2019 Jun 23:897190019850700. doi: 10.1177/0897190019850700. [Epub ahead of print]

PMID:
31232158
5.

With no lysine kinase 4 modulates sodium potassium 2 chloride cotransporter activity in vivo.

Terker AS, CastaƱeda-Bueno M, Ferdaus MZ, Cornelius RJ, Erspamer KJ, Su XT, Miller LN, McCormick JA, Wang WH, Gamba G, Yang CL, Ellison DH.

Am J Physiol Renal Physiol. 2018 Oct 1;315(4):F781-F790. doi: 10.1152/ajprenal.00485.2017. Epub 2018 Feb 7.

6.

Mutant Cullin 3 causes familial hyperkalemic hypertension via dominant effects.

Ferdaus MZ, Miller LN, Agbor LN, Saritas T, Singer JD, Sigmund CD, McCormick JA.

JCI Insight. 2017 Dec 21;2(24). pii: 96700. doi: 10.1172/jci.insight.96700.

7.

Drugs of Abuse and Addiction: An integrated approach to teaching.

Miller LN, Mercer SL.

Curr Pharm Teach Learn. 2017 May;9(3):405-414. doi: 10.1016/j.cptl.2017.01.003. Epub 2017 Apr 14.

PMID:
29233278
8.

Incidence of Self-Reported Depression Among Pharmacy Residents in Tennessee.

Mayberry KM, Miller LN.

Am J Pharm Educ. 2017 Oct;81(8):5960. doi: 10.5688/ajpe5960.

9.

Implementation of a human podocyte injury model of chronic kidney disease for profiling of renoprotective compounds.

Abraham VC, Miller LN, Pratt SD, Putman B, Kim L, Gopalakrishnan SM, King A.

Eur J Pharmacol. 2017 Nov 15;815:219-232. doi: 10.1016/j.ejphar.2017.09.006. Epub 2017 Sep 9.

PMID:
28899697
10.

Joint registry approach for identification of outlier prostheses.

de Steiger RN, Miller LN, Davidson DC, Ryan P, Graves SE.

Acta Orthop. 2013 Aug;84(4):348-52. doi: 10.3109/17453674.2013.831320.

11.

Loss to follow-up after arthroplasty: a new use for registry data.

Rowden NJ, Harrison JA, Graves SE, Miller LN, de Steiger RN, Davidson DC.

J Bone Joint Surg Br. 2012 Apr;94(4):493-6. doi: 10.1302/0301-620X.94B4.27532.

PMID:
22434465
12.

What is the benefit of introducing new hip and knee prostheses?

Anand R, Graves SE, de Steiger RN, Davidson DC, Ryan P, Miller LN, Cashman K.

J Bone Joint Surg Am. 2011 Dec 21;93 Suppl 3:51-4. doi: 10.2106/JBJS.K.00867.

PMID:
22262424
13.

Five-year results of the ASR XL Acetabular System and the ASR Hip Resurfacing System: an analysis from the Australian Orthopaedic Association National Joint Replacement Registry.

de Steiger RN, Hang JR, Miller LN, Graves SE, Davidson DC.

J Bone Joint Surg Am. 2011 Dec 21;93(24):2287-93. doi: 10.2106/JBJS.J.01727.

PMID:
22258775
14.

The impact of endorsing Spitzer's proposed criteria for PTSD in the forthcoming DSM-V on male and female Veterans.

Miller LN, Chard KM, Schumm JA, O'Brien C.

J Anxiety Disord. 2011 Jun;25(5):639-44. doi: 10.1016/j.janxdis.2011.02.004. Epub 2011 Feb 18.

PMID:
21411274
15.

Competing risks survival analysis applied to data from the Australian Orthopaedic Association National Joint Replacement Registry.

Gillam MH, Ryan P, Graves SE, Miller LN, de Steiger RN, Salter A.

Acta Orthop. 2010 Oct;81(5):548-55. doi: 10.3109/17453674.2010.524594.

16.

Outcome of primary resurfacing hip replacement: evaluation of risk factors for early revision.

Prosser GH, Yates PJ, Wood DJ, Graves SE, de Steiger RN, Miller LN.

Acta Orthop. 2010 Feb;81(1):66-71. doi: 10.3109/17453671003685434.

17.

Outcome of revision of unicompartmental knee replacement.

Hang JR, Stanford TE, Graves SE, Davidson DC, de Steiger RN, Miller LN.

Acta Orthop. 2010 Feb;81(1):95-8. doi: 10.3109/17453671003628731.

18.

Poor outcome of revised resurfacing hip arthroplasty.

de Steiger RN, Miller LN, Prosser GH, Graves SE, Davidson DC, Stanford TE.

Acta Orthop. 2010 Feb;81(1):72-6. doi: 10.3109/17453671003667176.

19.

Higher protein and energy intake is associated with increased weight gain in pre-term infants.

Collins CT, Chua MC, Rajadurai VS, McPhee AJ, Miller LN, Gibson RA, Makrides M.

J Paediatr Child Health. 2010 Mar;46(3):96-102. doi: 10.1111/j.1440-1754.2009.01645.x. Epub 2010 Jan 26.

PMID:
20105257
20.

Indol-3-yl-tetramethylcyclopropyl ketones: effects of indole ring substitution on CB2 cannabinoid receptor activity.

Frost JM, Dart MJ, Tietje KR, Garrison TR, Grayson GK, Daza AV, El-Kouhen OF, Miller LN, Li L, Yao BB, Hsieh GC, Pai M, Zhu CZ, Chandran P, Meyer MD.

J Med Chem. 2008 Mar 27;51(6):1904-12. doi: 10.1021/jm7011613. Epub 2008 Feb 27.

PMID:
18311894
21.

Discovery of 3-methyl-N-(1-oxy-3',4',5',6'-tetrahydro-2'H-[2,4'-bipyridine]-1'-ylmethyl)benzamide (ABT-670), an orally bioavailable dopamine D4 agonist for the treatment of erectile dysfunction.

Patel MV, Kolasa T, Mortell K, Matulenko MA, Hakeem AA, Rohde JJ, Nelson SL, Cowart MD, Nakane M, Miller LN, Uchic ME, Terranova MA, El-Kouhen OF, Donnelly-Roberts DL, Namovic MT, Hollingsworth PR, Chang R, Martino BR, Wetter JM, Marsh KC, Martin R, Darbyshire JF, Gintant G, Hsieh GC, Moreland RB, Sullivan JP, Brioni JD, Stewart AO.

J Med Chem. 2006 Dec 14;49(25):7450-65.

PMID:
17149874
22.

Acrylamide analog as a novel nitric oxide-independent soluble guanylyl cyclase activator.

Nakane M, Kolasa T, Chang R, Miller LN, Moreland RB, Brioni JD.

J Pharmacol Sci. 2006 Oct;102(2):231-8.

23.

Blockade of mGluR1 receptor results in analgesia and disruption of motor and cognitive performances: effects of A-841720, a novel non-competitive mGluR1 receptor antagonist.

El-Kouhen O, Lehto SG, Pan JB, Chang R, Baker SJ, Zhong C, Hollingsworth PR, Mikusa JP, Cronin EA, Chu KL, McGaraughty SP, Uchic ME, Miller LN, Rodell NM, Patel M, Bhatia P, Mezler M, Kolasa T, Zheng GZ, Fox GB, Stewart AO, Decker MW, Moreland RB, Brioni JD, Honore P.

Br J Pharmacol. 2006 Nov;149(6):761-74. Epub 2006 Oct 3.

24.

1-aryl-3-(4-pyridine-2-ylpiperazin-1-yl)propan-1-one oximes as potent dopamine D4 receptor agonists for the treatment of erectile dysfunction.

Kolasa T, Matulenko MA, Hakeem AA, Patel MV, Mortell K, Bhatia P, Henry R, Nakane M, Hsieh GC, Terranova MA, Uchic ME, Miller LN, Chang R, Donnelly-Roberts DL, Namovic MT, Hollingsworth PR, Martino B, El Kouhen O, Marsh KC, Wetter JM, Moreland RB, Brioni JD, Stewart AO.

J Med Chem. 2006 Aug 24;49(17):5093-109.

PMID:
16913699
25.

Synthesis and evaluation of 3-aryl piperidine analogs as potent and efficacious dopamine D4 receptor agonists.

Wang X, Bhatia PA, Daanen JF, Latsaw SP, Rohde J, Kolasa T, Hakeem AA, Matulenko MA, Nakane M, Uchic ME, Miller LN, Chang R, Moreland RB, Brioni JD, Stewart AO.

Bioorg Med Chem. 2005 Aug 1;13(15):4667-78.

PMID:
15896964
26.

Dopamine D2, but not D4, receptor agonists are emetogenic in ferrets.

Osinski MA, Uchic ME, Seifert T, Shaughnessy TK, Miller LN, Nakane M, Cox BF, Brioni JD, Moreland RB.

Pharmacol Biochem Behav. 2005 May;81(1):211-9.

PMID:
15894081
27.

Synthesis and activity of 2-[4-(4-[3H]-2-cyanophenyl)piperazinyl]-N-(2,4,6-[3H]3-3-methylphenyl)acetamide: a selective dopamine D4 receptor agonist and radioligand.

Matulenko MA, Surber B, Fan L, Kolasa T, Nakane M, Terranova MA, Uchic ME, Miller LN, Chang R, Donnelly-Roberts DL, Namovic MT, Moreland RB, Brioni JD, Stewart AO.

Bioorg Med Chem Lett. 2004 Oct 18;14(20):5095-8.

PMID:
15380206
28.

Comparative pharmacology of human dopamine D(2)-like receptor stable cell lines coupled to calcium flux through Galpha(qo5).

Moreland RB, Nakane M, Donnelly-Roberts DL, Miller LN, Chang R, Uchic ME, Terranova MA, Gubbins EJ, Helfrich RJ, Namovic MT, El-Kouhen OF, Masters JN, Brioni JD.

Biochem Pharmacol. 2004 Aug 15;68(4):761-72.

PMID:
15276084
29.

Discovery of 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole (ABT-724), a dopaminergic agent with a novel mode of action for the potential treatment of erectile dysfunction.

Cowart M, Latshaw SP, Bhatia P, Daanen JF, Rohde J, Nelson SL, Patel M, Kolasa T, Nakane M, Uchic ME, Miller LN, Terranova MA, Chang R, Donnelly-Roberts DL, Namovic MT, Hollingsworth PR, Martino BR, Lynch JJ 3rd, Sullivan JP, Hsieh GC, Moreland RB, Brioni JD, Stewart AO.

J Med Chem. 2004 Jul 15;47(15):3853-64.

PMID:
15239663
30.

Synthesis and functional activity of (2-aryl-1-piperazinyl)-N-(3-methylphenyl)acetamides: selective dopamine D4 receptor agonists.

Matulenko MA, Hakeem AA, Kolasa T, Nakane M, Terranova MA, Uchic ME, Miller LN, Chang R, Donnelly-Roberts DL, Namovic MT, Moreland RB, Brioni JD, Stewart AO.

Bioorg Med Chem. 2004 Jul 1;12(13):3471-83.

PMID:
15186832
31.

Dopamine D4 ligands and models of receptor activation: 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole and related heteroarylmethylarylpiperazines exhibit a substituent effect responsible for additional efficacy tuning.

Stewart AO, Cowart MD, Moreland RB, Latshaw SP, Matulenko MA, Bhatia PA, Wang X, Daanen JF, Nelson SL, Terranova MA, Namovic MT, Donnelly-Roberts DL, Miller LN, Nakane M, Sullivan JP, Brioni JD.

J Med Chem. 2004 Apr 22;47(9):2348-55.

PMID:
15084133
32.

A-350619: a novel activator of soluble guanylyl cyclase.

Miller LN, Nakane M, Hsieh GC, Chang R, Kolasa T, Moreland RB, Brioni JD.

Life Sci. 2003 Jan 17;72(9):1015-25.

PMID:
12495780
33.

Activation of soluble guanylate cyclase causes relaxation of corpus cavernosum tissue: synergism of nitric oxide and YC-1.

Nakane M, Hsieh G, Miller LN, Chang R, Terranova MA, Moreland RB, Kolasa T, Brioni JD.

Int J Impot Res. 2002 Apr;14(2):121-7.

34.

Discovery of FK 506 analogues that are nontoxic to mouse pancreatic beta cells in vitro but show diabetogenic potential when administered to the rat.

Mollison KW, Andrews JM, Fey TA, Miller LN, Krause RA, Bretheim PT, Brandt JA, Wagner R, Lane BC, Hsieh GC, Luly JR.

Transplant Proc. 1996 Dec;28(6):3185-8. No abstract available.

PMID:
8962236
35.

Evaluation of calcineurin's role in the immunosuppressive activity of FK 506, related macrolactams, and cyclosporine.

Lane BC, Miller LN, Kawai M, Or YS, Wiedeman P, Holzman TF, Luly JR.

Transplant Proc. 1993 Feb;25(1 Pt 1):644-6. No abstract available.

PMID:
7679829
36.

Dunaimycins, a new complex of spiroketal 24-membered macrolides with immunosuppressive activity. III. Immunosuppressive activities of dunaimycins.

Burres NS, Premachandran U, Frigo A, Swanson SJ, Mollison KW, Fey TA, Krause RA, Thomas VA, Lane B, Miller LN, et al.

J Antibiot (Tokyo). 1991 Dec;44(12):1331-41.

37.

Recognition of feline parovarian nodules as ectopic adrenocortical tissue.

Altera KP, Miller LN.

J Am Vet Med Assoc. 1986 Jul 1;189(1):71-2.

PMID:
3733505
38.

Redwoods: a population model debunked.

Brussard PF, Levin SA, Miller LN, Whittaker RH, Halbach K, Diem JE, McGregor JL.

Science. 1971 Oct 22;174(4007):435-6. No abstract available.

PMID:
17796093
39.

A surgical technic for correction of lateral patellar luxation in the dog.

Swaim SF, Miller LN.

Vet Med Small Anim Clin. 1969 Jun;64(6):512-7. No abstract available.

PMID:
5192660
40.

Terminology of cell-water relations.

Kramer PJ, Knipling EB, Miller LN.

Science. 1966 Aug 19;153(3738):889-90.

PMID:
17780651
41.

Chronic Gamma Radiation Affects the Distribution of Radial Increment in Pinus rigida Stems.

Woodwell GM, Miller LN.

Science. 1963 Jan 18;139(3551):222-3.

PMID:
17772083
42.

Product quieting of pencil shaping machine.

MILLER LN, HOOVER RM.

Am Ind Hyg Assoc J. 1958 Oct;19(5):412-4. No abstract available.

PMID:
13582865

Supplemental Content

Loading ...
Support Center